METHOD OF ENDOVITREAL TREATMENT OF RHEGMATOGENOUS RETINAL DETACHMENT Russian patent published in 2019 - IPC A61F9/07 A61F9/08 

FIELD: medicine.

SUBSTANCE: invention relates to medicine, specifically to ophthalmology. For surgical treatment of rhegmatogenous retinal detachment combined with posterior vitreous detachment, three punctures are made in flat part of ciliary body, subtotal vitrectomy, substitution of physiological solution and endolaser coagulation of retina around rupture. During the vitrectomy, the periphery and the retinal rupture area are scrapped with sclerocompression. That is followed by physiological solution replacement with air to the level of rupture and aspiration of the subretinal liquid in the air. Remaining physiologic solution is removed from vitreal cavity, endolaser coagulation of retina around rupture is performed with sclerocompression. Operation is completed by gas-air tamponade and removal of ports.

EFFECT: method enables intraoperative complete adhesion of eyeballs, excludes the need for introduction into the vitreous cavity of PFOC, and therefore reduces injuries by eliminating all possible complications associated with its use, time of surgical intervention.

1 cl, 2 ex